Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $572000.0.

  • Phibro Animal Health's Amortization of Deferred Charges rose 1349.21% to $572000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 million, marking a year-over-year increase of 6448.6%. This contributed to the annual value of $2.0 million for FY2025, which is 9375.0% up from last year.
  • As of Q4 2025, Phibro Animal Health's Amortization of Deferred Charges stood at $572000.0, which was up 1349.21% from $572000.0 recorded in Q3 2025.
  • Over the past 5 years, Phibro Animal Health's Amortization of Deferred Charges peaked at $572000.0 during Q1 2025, and registered a low of $147000.0 during Q4 2021.
  • For the 5-year period, Phibro Animal Health's Amortization of Deferred Charges averaged around $295400.0, with its median value being $240500.0 (2021).
  • Per our database at Business Quant, Phibro Animal Health's Amortization of Deferred Charges plummeted by 3348.42% in 2022 and then surged by 12000.0% in 2025.
  • Quarter analysis of 5 years shows Phibro Animal Health's Amortization of Deferred Charges stood at $147000.0 in 2021, then increased by 21.77% to $179000.0 in 2022, then surged by 45.25% to $260000.0 in 2023, then surged by 93.85% to $504000.0 in 2024, then rose by 13.49% to $572000.0 in 2025.
  • Its last three reported values are $572000.0 in Q4 2025, $572000.0 for Q3 2025, and $572000.0 during Q2 2025.